About Homology Medicines
Homology Medicines is a company based in Lexington (United States) founded in 2015 was acquired by Oxford BioMedica in January 2022.. Homology Medicines has raised $127 million across 3 funding rounds from investors including Fidelity Investments, Pfizer and OXB. The company has 221 employees as of December 31, 2022. Homology Medicines operates in a competitive market with competitors including BridgeBio, Spark Therapeutics, Alnylam, ATAI and Insitro, among others.
- Headquarter Lexington, United States
- Employees 221 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
$1.16 M-64as on Dec 31, 2023
-
Net Profit
$-112.96 M-2157as on Dec 31, 2023
-
EBITDA
$-101.43 M24as on Dec 31, 2023
-
Total Equity Funding
$127 M (USD)
in 3 rounds
-
Latest Funding Round
$60 M (USD), Post-IPO
Nov 09, 2020
-
Investors
Fidelity Investments
& 13 more
-
Employee Count
221
as on Dec 31, 2022
-
Acquired by
Oxford BioMedica
(Jan 28, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Leadership Team
8 people
Software Development Team
7 people
Research Team
5 people
Senior Team
4 people
Operations Team
4 people
Product Management Team
2 people
Human Resources and Administration
2 people
Scientific Team
1 people
Unlock access to complete
Funding Insights of Homology Medicines
Homology Medicines has successfully raised a total of $127M across 3 strategic funding rounds. The most recent funding activity was a Post-IPO round of $60 million completed in November 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Post-IPO — $60.0M
-
First Round
First Round
(16 Feb 2017)
- Investors Count 13
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2020 | Amount | Post-IPO - Homology Medicines | Valuation |
investors |
|
| Aug, 2017 | Amount | Series B - Homology Medicines | Valuation | Deerfield | |
| Feb, 2017 | Amount | Series A - Homology Medicines | Valuation | 5AM Ventures , Arch Venture Partners |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Homology Medicines
Homology Medicines has secured backing from 14 investors, including institutional and venture fund investors. Prominent investors backing the company include Fidelity Investments, Pfizer and OXB. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made in innovative life science companies globally.
|
Founded Year | Domain | Location | |
|
Early-stage and late-stage biotech and finance companies are funded.
|
Founded Year | Domain | Location | |
|
Venture capital and private equity firm
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Homology Medicines
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Homology Medicines
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Homology Medicines Comparisons
Competitors of Homology Medicines
Homology Medicines operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BridgeBio, Spark Therapeutics, Alnylam, ATAI and Insitro, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
RNA interference-based therapeutics are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| domain | founded_year | HQ Location |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| domain | founded_year | HQ Location |
Therapeutics for rare and ultra-rare metabolic diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Homology Medicines
Frequently Asked Questions about Homology Medicines
When was Homology Medicines founded?
Homology Medicines was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Where is Homology Medicines located?
Homology Medicines is headquartered in Lexington, United States. It is registered at Lexington, Kentucky, United States.
Is Homology Medicines a funded company?
Homology Medicines is a funded company, having raised a total of $127M across 3 funding rounds to date. The company's 1st funding round was a Series A of $43.5M, raised on Feb 16, 2017.
How many employees does Homology Medicines have?
As of Dec 31, 2022, the latest employee count at Homology Medicines is 221.
What is the annual revenue of Homology Medicines?
Annual revenue of Homology Medicines is $1.16M as on Dec 31, 2023.
What does Homology Medicines do?
Homology Medicines was established in 2015 in Lexington, United States, within the biotechnology sector. Gene therapies targeting rare genetic diseases are developed through a proprietary platform. This platform relies on gene editing and adeno-associated virus vectors sourced from natural human variants. Homologous recombination, a naturally occurring biological process, is harnessed to enable precise genetic modifications. Operations focus on advancing these therapies for clinical applications.
Who are the top competitors of Homology Medicines?
Homology Medicines's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.
Who are Homology Medicines's investors?
Homology Medicines has 14 investors. Key investors include Fidelity Investments, Pfizer, OXB, Temasek, and Arch Venture Partners.